Use of Spinal Cord Stimulators in Patients With Pacemakers or Implantable Cardiac Defibrillators: A Review of Documented Accounts of Interference.
Neuromodulation
; 26(1): 43-56, 2023 Jan.
Article
en En
| MEDLINE
| ID: mdl-34327771
ABSTRACT
OBJECTIVES:
To assess the currently available evidence regarding associations between spinal cord stimulator (SCS) lead type, clinical indications for device placement, and interference between SCSs and cardiac pacemakers (CPMs)/implantable cardioverter-defibrillators (ICDs). STUDYDESIGN:
Review of case reports and original research studies assessing the interference between SCS and CPM/ICD. MATERIALS ANDMETHODS:
PubMed and Cochrane databases were searched for articles commenting on the interference between SCS and CPM/ICD. The search criteria which generated the greatest number of relevant studies was (spinal cord stimulator AND [pacemaker OR implantable cardioverter defibrillator]). Additional, empiric review was conducted using JSTOR, ScienceDirect, and EBSCOhost databases; however, no additional eligible studies were identified. Data were extracted, summarized into tables, and quantitatively analyzed using LibreTexts and MedCalc software.RESULTS:
There was no statistically significant interference observed between SCS and CPM/ICD devices in patients regardless of indication for SCS placement and SCS lead polarity.LIMITATIONS:
Limited by variability of patient cases and variability in maximum frequency and amplitude of SCS devices tried in individual cases. Also limited by small sample size and the absence of a standard definition for device interference across studies.CONCLUSIONS:
Interference between cardiac devices and SCSs is a rare occurrence. As there are currently no published guidelines, devices should be interrogated on a case-by-case basis in the SCS trial period (if implanted after cardiac device), during permanent implantation, and during scheduled follow-up visits. Peri-operative testing should include increasing the SCS settings to maximally tolerated levels with cardiac device set at its maximum sensitivity.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Marcapaso Artificial
/
Terapia por Estimulación Eléctrica
/
Desfibriladores Implantables
Tipo de estudio:
Guideline
/
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Neuromodulation
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos